Excerpt Eli Lilly and Company have launched the Leonard Award, to acknowledge a diverse group of five individuals working to advance diabetes management through innovative thinking and novel approaches. Lilly will donate a… read more

Excerpt Bio-Thera Solutions, a biopharmaceutical company based in Guangzhou, China, has initiated the first Phase 3 study of a golimumab biosimilar in China and Eastern Europe, which is expected to enrol 598 subjects… read more

Excerpt Lonza and ValenzaBio have entered an agreement for the accelerated manufacturing of VB421, an anti-insulin-like growth factor 1 receptor (anti-IGF-1R) under evaluation for the treatment of thyroid eye disease (TED) and other… read more

Excerpt Theramex, a global speciality pharmaceutical company dedicated to women’s health, has signed an agreement with Enzene Biosciences Ltd., Pune, India, to register and commercialise denosumab for use in Europe, the UK, Switzerland,… read more

A leading third-party manufacturer in the small molecule active pharmaceutical ingredient (API) and finished formulation industry, Fareva entered the biologics CDMO sector last year, subsequently acquiring an oncology injectable facility in Pau, Southwestern… read more

GlaxoSmithKline (GSK) and Vir Biotechnology have applied for emergency use authorization (EUA) from the US FDA for VIR-7831 (GSK4182136), an investigational dual-action antibody designed to treat Covid-19 in adults and adolescents aged 12… read more

Japanese multinational conglomerate Fujifilm has made a capital investment of JPY100bn ($928m) for the expansion of its subsidiary Fujifilm Diosynth Biotechnologies’ (FDB) biologics production facility in Hillerod, Denmark. This investment envisions a doubling… read more

Immuno-oncology company Agenus Inc. has submitted a Biologics License Application (BLA) to the U.S. FDA for the accelerated approval of its anti-PD-1 antibody, balstilimab, for the treatment of patients with recurrent or metastatic… read more

Biotechnology company BeiGene has announced approval from the China National Medical Products Administration (NMPA) to commence the manufacturing of tislelizumab, its anti-PD-1 antibody. This is to begin immediately at its million square foot… read more

Roche's arthritis drug tocilizumab cuts the risk of death among patients hospitalised with severe COVID-19, also shortening the time to recovery and reducing the need for mechanical ventilation, results of a large trial… read more